Oncotarget SCD1 Inhibition Strategy Shows Potent Synergy with Regorafenib and Metformin in Tumor Cell Killing Our data demonstrates that UM cells are killed by treatment with aramchol plus regorafenib plus... read more April 21, 2026
Oncotarget The Obesity Paradox, Metformin and Lung Cancer In a new editorial, researchers from Instituto Nacional de Cancerología discuss the "obesity paradox"... read more July 27, 2023
Oncotarget Could Metformin and Rapamycin Replace Maintenance Chemotherapy? Researchers explored metformin with or without rapamycin as maintenance therapy in patients with metastatic pancreatic... read more December 16, 2021
Oncotarget Are Anti-aging Drugs the Key to Cancer Prevention? In his recent paper, Dr. Mikhail Blagosklonny explains his perspective on the current landscape of... read more February 3, 2021